Covaxin’s Phase 3 Trial Data Looks Good, Says Chief Scientist As Bharat Biotech Awaits WHO Approval

The overall efficacy is quite high. The vaccine efficacy against the Delta variant is low but it is still quite good, said Dr Soumya Swaminathan.

Similar Articles

Most Popular